Kaken Pharmaceutical Co Financial Overview
Kaken Pharmaceutical Co's market cap is currently $920.90M. The company's EPS TTM is $0.12217260000000002; its P/E ratio is 179.17; and it has a dividend yield of 4.34%. Kaken Pharmaceutical Co is scheduled to report earnings on November 10, 2025, and the estimated EPS forecast is $0.16. See an overview of income statement, balance sheet, and cash flow financials.
